Generation ex vivo of TGF-β-producing regulatory T cells from CD4+CD25- precursors

被引:382
作者
Zheng, SG [1 ]
Gray, JD [1 ]
Ohtsuka, K [1 ]
Yamagiwa, S [1 ]
Horwitz, DA [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Dept Med, Div Rheumatol & Immunol, Los Angeles, CA 90033 USA
关键词
D O I
10.4049/jimmunol.169.8.4183
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previously we reported that TGF-beta has an important role in the generation and expansion of human "professional" CD4(+)CD25(+) regulatory T cells in the periphery that have a cytokine-independent mechanism of action. In this study we used low-dose staphylococcal enterotoxin to induce T cell-dependent Ab production. We report that TGF-beta induces activated CD4(+)CD25(-) T cells to become Th3 suppressor cells. While stimulating CD4(+) cells with TGF-beta modestly increased expression of CD25 and intracellular CTLA-4 in primary cultures, upon secondary stimulation without TGF-beta the total number and those expressing these markers dramatically increased. This expansion was due to both increased proliferation and protection of these cells from activation-induced apoptosis. Moreover, adding as few as 1% of these TGF-beta-primed CD4(+) T cells to fresh CD4(+) cells and B cells markedly suppressed IgG production. The inhibitory effect was mediated by TGF-beta and was also partially contact dependent. Increased TGF-beta production was associated with a decreased production of IFN-gamma and IL-10. Depletion studies revealed that the precursors of these TGF-beta-producing CD4(+) suppressor cells were CD25 negative. These studies provide evidence that CD4(+)CD25(+) regulatory cells in human blood consist of at least two subsets that have TGF-beta-dependent and independent mechanisms of action. TGF-beta has an essential role in the generation of both of these T suppressor cell subsets from peripheral T cells. The ability to induce CD4(+) and CD8(+) cells to become regulatory cells ex vivo has the potential to be useful in the treatment of autoimmune diseases and to prevent transplant rejection.
引用
收藏
页码:4183 / 4189
页数:7
相关论文
共 32 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]   MECHANISM OF K562-INDUCED HUMAN NATURAL-KILLER CELL INACTIVATION USING HIGHLY ENRICHED EFFECTOR-CELLS ISOLATED VIA A NEW SINGLE-STEP SHEEP ERYTHROCYTE ROSETTE ASSAY [J].
ABRAMS, SI ;
BRAHMI, Z .
ANNALES DE L INSTITUT PASTEUR-IMMUNOLOGY, 1988, 139 (04) :361-381
[3]   CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 [J].
Annacker, O ;
Pimenta-Araujo, R ;
Burlen-Defranoux, O ;
Barbosa, TC ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3008-3018
[4]  
Cerwenka A, 1996, J IMMUNOL, V156, P459
[5]  
CERWENKA A, 1994, J IMMUNOL, V153, P4367
[6]   Requirement for transforming growth factor β1 in controlling T cell apoptosis [J].
Chen, WJ ;
Jin, WW ;
Tian, HS ;
Sicurello, P ;
Frank, M ;
Orenstein, JM ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :439-453
[7]   A SIMPLE METHOD FOR THE PURIFICATION OF HUMAN PERIPHERAL-BLOOD MONOCYTES - A SUBSTITUTE FOR SEPRACELL-MN [J].
DENHOLM, EM ;
WOLBER, FM .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 144 (02) :247-251
[8]   Oral tolerance: Mechanisms and therapeutic applications [J].
Faria, AMC ;
Weiner, HL .
ADVANCES IN IMMUNOLOGY, VOL 73, 1999, 73 :153-264
[9]   Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo [J].
Gavin, MA ;
Clarke, SR ;
Negrou, E ;
Gallegos, A ;
Rudensky, A .
NATURE IMMUNOLOGY, 2002, 3 (01) :33-41
[10]   Transforming growth factor β1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc [J].
Genestier, L ;
Kasibhatla, S ;
Brunner, K ;
Green, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :231-239